A historic shift in Canadian drug policy has happened, as the regulators permit the availability of psilocybin mushrooms for therapeutic applications. Before this, these substances were strictly restricted, but a increasing body of evidence suggests they potentially offer relief for mental health issues like anxiety. The new policy represents a maj